Don't forget Enron, WorldCom, they still have a ways to go. Mgmt is still striving! Or should I say thriving (through dumping of shares).
wow, that's terrible. if you had sold on July 15, you would have made as you as you could ever make with all of the contingency milestones, which could take years.
It could be that Cubist's reporting of Difficid income reflect badly on sales. Does anyone out there know what 3.7 million in Cubist royalties translates to overall Difficid sales?
Two more members of senior management leave, including the CEO, on top of the firing of three senior managers last year plus the founder. Crazy. Anyone know what these compliance issues are?
Not a close follower of the stock, could you please give a short version of what they are voting on? Thanks in advance.
Does anyone know if Ligand has any royalty arrangement with the drugs they sold to Eisai, especially Targretin?
Relatively low sales, numerous difficult to partner assets, with a vivid enough imagination one can see the interest from big pharma...
Not bad Michel. You didn't get the company right but who cares? It is all about making $ anyway.
I thought the same thing. It is hard to know if it is real demand or channel stuffing, which is probably why the stock is in a holding pattern.